Aug. 26, 2026 – The Cardiovascular Research Foundation (CRF) announced the late-breaking clinical trials and science selected for presentation at TCT 2026, the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine. This year’s conference will take place Oct. 31–Nov. 3 in San Diego, Calif.
For more than three decades, TCT has been at the forefront of advancing cardiovascular medicine, serving as the global stage for groundbreaking research and innovation. The meeting is recognized for unveiling pivotal data that informs clinical decision-making, drives practice-changing innovation, and ultimately improves outcomes for patients with heart and vascular disease.
Among the most highly anticipated presentations at TCT are the Late-Breaking Clinical Trials and Science sessions, which provide first access to landmark research findings, emerging therapies, novel devices, and cutting-edge treatment strategies.
This year, 28 studies will be featured, highlighting advances in minimally invasive interventions, pharmaceutical therapies, and breakthrough technologies designed to prevent, manage, and treat cardiovascular disease.
Click here to access the agenda for the late-breaking clinical trials and science presentations.
Receive updates on X at https://x.com/TCTConference and https://x.com/crfheart.
August 21, 2026 
